P1234: REAL-WORLD EXPERIENCE OF OUTCOMES WITH GLOFITAMAB SALVAGE THERAPY FOR RELAPSE/REFRACTORY B-CELL LYMPHOMA IN TAIWAN: MINIMAL SAFETY CONCERN WITH HEPATITIS B REACTIVATION

Detalles Bibliográficos
Autores principales: Wu, S.-J., Liao, C.-K., Wang, Y.-W., Wang, M.-C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430334/
http://dx.doi.org/10.1097/01.HS9.0000847800.04742.1b
_version_ 1784779738484572160
author Wu, S.-J.
Liao, C.-K.
Wang, Y.-W.
Wang, M.-C.
author_facet Wu, S.-J.
Liao, C.-K.
Wang, Y.-W.
Wang, M.-C.
author_sort Wu, S.-J.
collection PubMed
description
format Online
Article
Text
id pubmed-9430334
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94303342022-08-31 P1234: REAL-WORLD EXPERIENCE OF OUTCOMES WITH GLOFITAMAB SALVAGE THERAPY FOR RELAPSE/REFRACTORY B-CELL LYMPHOMA IN TAIWAN: MINIMAL SAFETY CONCERN WITH HEPATITIS B REACTIVATION Wu, S.-J. Liao, C.-K. Wang, Y.-W. Wang, M.-C. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430334/ http://dx.doi.org/10.1097/01.HS9.0000847800.04742.1b Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Wu, S.-J.
Liao, C.-K.
Wang, Y.-W.
Wang, M.-C.
P1234: REAL-WORLD EXPERIENCE OF OUTCOMES WITH GLOFITAMAB SALVAGE THERAPY FOR RELAPSE/REFRACTORY B-CELL LYMPHOMA IN TAIWAN: MINIMAL SAFETY CONCERN WITH HEPATITIS B REACTIVATION
title P1234: REAL-WORLD EXPERIENCE OF OUTCOMES WITH GLOFITAMAB SALVAGE THERAPY FOR RELAPSE/REFRACTORY B-CELL LYMPHOMA IN TAIWAN: MINIMAL SAFETY CONCERN WITH HEPATITIS B REACTIVATION
title_full P1234: REAL-WORLD EXPERIENCE OF OUTCOMES WITH GLOFITAMAB SALVAGE THERAPY FOR RELAPSE/REFRACTORY B-CELL LYMPHOMA IN TAIWAN: MINIMAL SAFETY CONCERN WITH HEPATITIS B REACTIVATION
title_fullStr P1234: REAL-WORLD EXPERIENCE OF OUTCOMES WITH GLOFITAMAB SALVAGE THERAPY FOR RELAPSE/REFRACTORY B-CELL LYMPHOMA IN TAIWAN: MINIMAL SAFETY CONCERN WITH HEPATITIS B REACTIVATION
title_full_unstemmed P1234: REAL-WORLD EXPERIENCE OF OUTCOMES WITH GLOFITAMAB SALVAGE THERAPY FOR RELAPSE/REFRACTORY B-CELL LYMPHOMA IN TAIWAN: MINIMAL SAFETY CONCERN WITH HEPATITIS B REACTIVATION
title_short P1234: REAL-WORLD EXPERIENCE OF OUTCOMES WITH GLOFITAMAB SALVAGE THERAPY FOR RELAPSE/REFRACTORY B-CELL LYMPHOMA IN TAIWAN: MINIMAL SAFETY CONCERN WITH HEPATITIS B REACTIVATION
title_sort p1234: real-world experience of outcomes with glofitamab salvage therapy for relapse/refractory b-cell lymphoma in taiwan: minimal safety concern with hepatitis b reactivation
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430334/
http://dx.doi.org/10.1097/01.HS9.0000847800.04742.1b
work_keys_str_mv AT wusj p1234realworldexperienceofoutcomeswithglofitamabsalvagetherapyforrelapserefractorybcelllymphomaintaiwanminimalsafetyconcernwithhepatitisbreactivation
AT liaock p1234realworldexperienceofoutcomeswithglofitamabsalvagetherapyforrelapserefractorybcelllymphomaintaiwanminimalsafetyconcernwithhepatitisbreactivation
AT wangyw p1234realworldexperienceofoutcomeswithglofitamabsalvagetherapyforrelapserefractorybcelllymphomaintaiwanminimalsafetyconcernwithhepatitisbreactivation
AT wangmc p1234realworldexperienceofoutcomeswithglofitamabsalvagetherapyforrelapserefractorybcelllymphomaintaiwanminimalsafetyconcernwithhepatitisbreactivation

Ejemplares similares